Alcidion Group Limited · ASX:ALC
Alcidion — Investor Presentation (June 2021)
15 slides from Alcidion's investor presentation, Jun 30, 2021
Slide 1: UK-Focused Webinar Presentation (ASX announcement)
30 June 2021 Australian Securities Exchange 20 Bridge Street, Sydney NSW 2000 For personal use only UK-Focused Webinar Presentation Melbourne, Australia – Alcidion Group Limited (ASX: ALC) Managing Director, Kate Quirke, and UK Managing Director, Lynette Ousby, yesterday hosted a UK-focused webinar
Slide 2: Investor Presentation: UK Webinar – Market Position and Opportunity
For personal use only Investor Presentation UK Webinar – Market Position and Opportunity Lynette Ousby, UK Managing Director Kate Quirke, Group Managing Director 29 June 2021 1
Slide 3: Agenda
Agenda For personal use only •1 Driven and experienced UK Team established •2 Alcidion in the UK •3 Overview – UK Market Dynamics •4 NHSX – Acceleration of the Digital Strategy •5 Digital strategy provides potential to disrupt large EPR vendors •6 Increasing importance of the ICS in UK market •7 Cur
Slide 4: Driven & highly Experienced UK Team
Driven & highly Experienced UK Team For personal use only UK Team UK Managing Director – Lynette Ousby • Investment in UK team over past 2 years, grew staff head count • 20+ yrs experience in customer service, from 10 to 35 business transformation and operations across healthcare IT & finance sector
Slide 5: Alcidion in the UK
Alcidion in the UK For personal use only Alcidion acquires $16.2m Placement NHS Lanarkshire Miya Precision East Lancashire MKM Health & Funds primarily used to 5-year contract to deploy formally launches in UK Contract across 5 hospitals for Patientrack build sales, marketing & Patientrack to 3rd la
Slide 6: Overview – UK Market Dynamics
Overview – UK Market Dynamics For personal use only For Illustrative Purposes Only Government Bodies NHS England + NHSX Alcidion’s Customer (Future, ICS* ICS #1 ICS #2 (42) albeit still emerging) Trusts Alcidion’s Customer (Today) T #1 T #2 T #3 T #4 T #5 T #6 (~146 Acute) Hospitals H1 H2 H3 H4 H5 H
Slide 7: NHSX – Acceleration of the Digital Strategy
NHSX – Acceleration of the Digital Strategy For personal use only Core Pillars of the Digital Strategy (EPR Strategy) • NHSX: joint unit of NHS England and the Department of Health and Social Care, supporting local NHS and care organisations to: Openness Ability to integrate with other platforms and
Slide 8: Digital strategy provides potential to disrupt large EPR vendors
Digital strategy provides potential to disrupt large EPR vendors For personal use only NHS + digital health market changing in UK, leading to growing adoption of larger integrated EPR contracts • Concept of an EPR is maturing in the UK; market moving from standalone PAS to an integrated EPR given in
Slide 9: Increasing Importance of ICS in UK Market
Increasing Importance of ICS in UK Market For personal use only What are Integrated Care Systems (ICS)? 42 • Partnerships that bring together NHS health services across a geographical area (i.e. aggregation of Trusts (who may have multiple hospitals) in a region) ICSs across England • Aim to integra
Slide 10: Current UK Market Penetration
Current UK Market Penetration For personal use only Material revenue upside driven by product module upsell, along with new customer wins Alcidion NHS penetration in UK Market Contract Size Upside Potential Large EPR vendors Accessible for Alcidion Total Acute 27 (~19%) 145 Approx. Trusts in UK NHS
Slide 11: Acquisition of ExtraMed
Acquisition of ExtraMed For personal use only Long-standing UK market leader in patient flow, addressing key pain-points for hospital administrative staff Business Overview Value Proposition • Leading UK provider with 20+ year track record providing patient flow management software • 9 long-standing
Slide 12: Salford – opportunity to partner with Hitachi
Salford – opportunity to partner with Hitachi For personal use only Building the UK’s first ‘Digital Control Centre’, a fully integrated digital transformation of care processes • ExtraMed awarded sub-contract for patient flow management as part of £25m large- scale IT project with lead contractor,
Slide 13: UK Growth Strategy
UK Growth Strategy For personal use only Accelerating sales in the UK as part of becoming a leading global healthcare technology organisation 1 Upsell Miya Precision (or other modules) to existing Alcidion customers 2 Win new Miya Precision installs 3 Listed on Procurement Frameworks (to leverage Di
Slide 14: Disclaimer
Disclaimer For personal use only The information contained in this document (“Document”) has been prepared by Alcidion Group Limited ACN 143 142 410 (referred to as “Alcidion” or “Company”). This Document is current as at the date of this Document and should be read in conjunction with other Alcidio
Slide 15: For personal use only
For personal use only